Characterization and comparison of transgenic Artemisia annua GYR and wild-type NON-GYR plants in an environmental release trial
“Characterization and comparison of transgenic Artemisia annua GYR and wild-type NON-GYR plants in an environmental release trial”, vol. 15, p. -, 2016.
, The anti-malarial drug, artemisinin, is quite expensive as a result of its slow content in Artemisia annua. Recent investigations have suggested that genetic engineering of A. annua is a promising approach to improve the yield of artemisinin. In this study, the transgenic A. annua strain GYR, which has high artemisinin content, was evaluated in an environmental release trial.